First-line Therapy in Metastatic PDAC

Clinical trial NCT03487016 · UNKNOWN

Trial details

NCT number: NCT03487016
Sponsor: Ludwig-Maximilians - University of Munich
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2019-02-15
Primary completion: 2022-07-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.